1K Kirana raises Series B funding of USD 25 Mn for hyperlocal shopping

1K Kirana raises Series B funding of USD 25 Mn for hyperlocal shopping

Published: 8 hours ago By Saipriya Iyer

Indian startup 1K Kirana has reportedly secured a Series B funding of USD 25 million in a bid to help neighborhood stores and brands reach more consumers. This funding round was initiated by Info Edge Ventures, Kae Capital, and Alpha Wav....

KOR-based Hanmi Fine Chemical expands to high-tech CDMO services

Hanmi Fine Chemical, a Hanmi Pharmaceutical Group subsidiary, has reportedly expanded its business from existing APIs (Active Pharmaceutical Ingredient) to high-tech CDMO services. Owing to the pandemic, the demand for synthetic, high-le....

UZ Brussel begins breast cancer treatment with Brainlab DIBH technology

Clinicians at UZ Brussel are reportedly the first to treat breast cancer patients with Brainlab’s new DIBH (Deep Inspiration Breath Hold) technology. The technology is developed to optimize SGRT and IGRT (surface guided and image-g....

Coveted nail brand Nailboo secures Sally Beauty as first retail partner

Nailboo, one of the flagship brands of beauty and wellness company Underlining, has reportedly secured Sally Beauty as its first retailer partner. Underlining CEO and Co-Founder Razvan Romanescu mentioned that this is a huge achievement ....

BeiGene opens regional office in SUI to reinforce European presence

Global biotech company BeiGene Ltd has reportedly opened a regional office in Basel, Switzerland to serve as a European operational hub for the company. John V. Oyler, Chairman, Co-Founder, and CEO at BeiGene stated that the new office i....

NielsenIQ unveils SaaS solution to measure ROI & monetize assets

NielsenIQ Consumer LLC, an information services company, has reportedly launched NielsenIQ Activate, a SaaS (software-as-a-service) solution. This retail media solution will allow retailers to expedite revenue opportunities through compreh....

Inmagene receives FDA IND approval for third-gen BTK inhibitor

Inmagene Biopharmaceuticals, a clinical-stage biotech company, has reportedly announced that the U.S. FDA (Food and Drug Administration) has approved its IND (investigational new drug) application for IMG-004 drug candidate. For the unve....

Industry Updates

Analyzing  RVs  market dynamics over 2021-2026
Analyzing RVs market dynamics over 2021-2026
By Admin  Published: 7 minutes ago